TUESDAY, Feb. 21 (HealthDay News) -- Medtronic's Resolute Integrity Drug-Eluting Stent has been approved by the U.S. Food and Drug Administration for people with coronary artery disease (CAD), the Minneapolis-based company said in a news release.
A stent is a hollow mesh tube used to prop open a narrowed coronary vessel. Medtronic's Resolute Integrity DES is made from a drug-coated polymer material and resembles a flexible spring,
The device performed strongly in clinical studies, including among people with diabetes, a common contributor to CAD, Medtronic said.
CAD is the leading cause of death in the United States, killing almost 500,000 people annually, the company said.
Medline Plus has more about coronary artery disease.
Copyright © 2012 HealthDay. All rights reserved.
|Previous: FDA Moves to Head Off Shortages of 2 Cancer Drugs||Next: Type 1 Diabetes May Develop More Slowly Than Thought|
Reader comments on this article are listed below. Review our comments policy.
Submit your opinion:
Are you a Doctor, Pharmacist, PA or a Nurse?
Join the Doctors Lounge online medical community